The Three-Way Pendulum of Healthcare Innovation.
Biomed Hub
; 2(Suppl 1): 22-25, 2017.
Article
em En
| MEDLINE
| ID: mdl-31988926
ABSTRACT
We are, understandably, forever hearing about the high cost of bringing innovative new drugs and treatments to the healthcare market, especially medicines for smaller subgroups, and the fact that member state health systems often baulk at the prices. This article will argue that such a bypassing and blocking of innovative medicines and treatments is not only counterproductive when it comes to the health of Europe's patients, but actually fails to take into account the economic arguments. The article seeks to show that the long-term benefit to patients and the economy (health means wealth) will outweigh initial costs down the line. Couple this with a smarter use of information technologies and other resources and it will be possible to get much closer to building sustainable healthcare systems in a Europe struggling under the burden of an ageing population.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Health_technology_assessment
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article